Unihealth Hospitals Statistics
Total Valuation
NSE:UNIHEALTH has a market cap or net worth of INR 4.37 billion. The enterprise value is 5.00 billion.
| Market Cap | 4.37B |
| Enterprise Value | 5.00B |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:UNIHEALTH has 15.40 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 15.40M |
| Shares Outstanding | 15.40M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 35.57% |
| Owned by Institutions (%) | n/a |
| Float | 9.92M |
Valuation Ratios
The trailing PE ratio is 17.37.
| PE Ratio | 17.37 |
| Forward PE | n/a |
| PS Ratio | 5.53 |
| PB Ratio | 2.43 |
| P/TBV Ratio | 3.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.78, with an EV/FCF ratio of -20.85.
| EV / Earnings | 19.89 |
| EV / Sales | 6.33 |
| EV / EBITDA | 13.78 |
| EV / EBIT | 16.06 |
| EV / FCF | -20.85 |
Financial Position
The company has a current ratio of 5.80, with a Debt / Equity ratio of 0.10.
| Current Ratio | 5.80 |
| Quick Ratio | 5.22 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.49 |
| Debt / FCF | -0.73 |
| Interest Coverage | 52.95 |
Financial Efficiency
Return on equity (ROE) is 25.60% and return on invested capital (ROIC) is 16.39%.
| Return on Equity (ROE) | 25.60% |
| Return on Assets (ROA) | 11.54% |
| Return on Invested Capital (ROIC) | 16.39% |
| Return on Capital Employed (ROCE) | 15.62% |
| Weighted Average Cost of Capital (WACC) | -5.06% |
| Revenue Per Employee | 1.58M |
| Profits Per Employee | 502,466 |
| Employee Count | 500 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 9.56 |
Taxes
| Income Tax | -2.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94.14% in the last 52 weeks. The beta is -1.75, so NSE:UNIHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | -1.75 |
| 52-Week Price Change | +94.14% |
| 50-Day Moving Average | 291.29 |
| 200-Day Moving Average | 196.00 |
| Relative Strength Index (RSI) | 46.76 |
| Average Volume (20 Days) | 27,850 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:UNIHEALTH had revenue of INR 789.82 million and earned 251.23 million in profits. Earnings per share was 16.31.
| Revenue | 789.82M |
| Gross Profit | 514.36M |
| Operating Income | 308.82M |
| Pretax Income | 344.38M |
| Net Income | 251.23M |
| EBITDA | 360.27M |
| EBIT | 308.82M |
| Earnings Per Share (EPS) | 16.31 |
Balance Sheet
The company has 84.92 million in cash and 175.98 million in debt, with a net cash position of -91.07 million or -5.91 per share.
| Cash & Cash Equivalents | 84.92M |
| Total Debt | 175.98M |
| Net Cash | -91.07M |
| Net Cash Per Share | -5.91 |
| Equity (Book Value) | 1.79B |
| Book Value Per Share | 81.31 |
| Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was -79.16 million and capital expenditures -160.43 million, giving a free cash flow of -239.59 million.
| Operating Cash Flow | -79.16M |
| Capital Expenditures | -160.43M |
| Free Cash Flow | -239.59M |
| FCF Per Share | -15.56 |
Margins
Gross margin is 65.12%, with operating and profit margins of 39.10% and 31.81%.
| Gross Margin | 65.12% |
| Operating Margin | 39.10% |
| Pretax Margin | 43.60% |
| Profit Margin | 31.81% |
| EBITDA Margin | 45.61% |
| EBIT Margin | 39.10% |
| FCF Margin | n/a |
Dividends & Yields
NSE:UNIHEALTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 5.76% |
| FCF Yield | -5.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |